{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:06:53Z","timestamp":1761487613861},"reference-count":53,"publisher":"Elsevier BV","issue":"37-39","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.vaccine.2006.05.025","type":"journal-article","created":{"date-parts":[[2006,6,7]],"date-time":"2006-06-07T02:55:54Z","timestamp":1149648954000},"page":"6340-6350","source":"Crossref","is-referenced-by-count":21,"title":["Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge"],"prefix":"10.1016","volume":"24","author":[{"given":"Julia","family":"Vipond","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Vipond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Allen-Vercoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon O.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham J.","family":"Hatch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen E.","family":"Gooch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Bacon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toby","family":"Hampshire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Shuttleworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel P.","family":"Minton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Blake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip D.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5\u20136","key":"10.1016\/j.vaccine.2006.05.025_bib1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.micinf.2005.03.013","article-title":"TB subunit vaccines-putting the pieces together","volume":"7","author":"Andersen","year":"2005","journal-title":"Microbes Infect"},{"issue":"8986","key":"10.1016\/j.vaccine.2006.05.025_bib2","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2006.05.025_bib3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0020-7519(03)00061-4","article-title":"Recent progress in the development and testing of vaccines against human tuberculosis","volume":"33","author":"McMurray","year":"2003","journal-title":"Int J Parasitol"},{"issue":"6685","key":"10.1016\/j.vaccine.2006.05.025_bib4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2006.05.025_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tube.2004.09.001","article-title":"The tuberculosis vaccine challenge","volume":"85","author":"Brennan","year":"2005","journal-title":"Tuberculosis (Edinburgh)"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2006.05.025_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tube.2004.09.008","article-title":"NIH pre-clinical screening program: overview and current status","volume":"85","author":"Izzo","year":"2005","journal-title":"Tuberculosis (Edinburgh)"},{"issue":"3","key":"10.1016\/j.vaccine.2006.05.025_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1046-2023(03)00135-X","article-title":"DNA vaccine strategies: candidates for immune modulation and immunization regimens","volume":"31","author":"Doria-Rose","year":"2003","journal-title":"Methods"},{"issue":"8","key":"10.1016\/j.vaccine.2006.05.025_bib8","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/nm0896-888","article-title":"Vaccination against tuberculosis by DNA injection","volume":"2","author":"Tascon","year":"1996","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.vaccine.2006.05.025_bib9","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm0896-893","article-title":"Immunogenicity and protective efficacy of a tuberculosis DNA vaccine","volume":"2","author":"Huygen","year":"1996","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.vaccine.2006.05.025_bib10","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0264-410X(97)00073-X","article-title":"Protection against tuberculosis by a plasmid DNA vaccine","volume":"15","author":"Lowrie","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.05.025_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1472-9792(02)00080-X","article-title":"Prospects for a better vaccine against tuberculosis","volume":"83","author":"Reed","year":"2003","journal-title":"Tuberculosis (Edinburgh)"},{"issue":"27","key":"10.1016\/j.vaccine.2006.05.025_bib12","doi-asserted-by":"crossref","first-page":"12574","DOI":"10.1016\/S0021-9258(18)67127-3","article-title":"The functional domains of coagulation factor VIII:C","volume":"261","author":"Burke","year":"1986","journal-title":"J Biol Chem"},{"issue":"14","key":"10.1016\/j.vaccine.2006.05.025_bib13","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1093\/nar\/19.14.3979","article-title":"Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells","volume":"19","author":"Chapman","year":"1991","journal-title":"Nucl Acids Res"},{"issue":"12","key":"10.1016\/j.vaccine.2006.05.025_bib14","doi-asserted-by":"crossref","first-page":"6112","DOI":"10.4049\/jimmunol.159.12.6112","article-title":"Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites","volume":"159","author":"Leitner","year":"1997","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.05.025_bib15","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/0006-291X(91)91713-M","article-title":"Signal and propeptide processing of human tissue plasminogen activator: activity of a pro-tPA derivative","volume":"179","author":"Berg","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.vaccine.2006.05.025_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1054\/tuld.1998.0196","article-title":"Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A","volume":"79","author":"Baldwin","year":"1999","journal-title":"Tuber Lung Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2006.05.025_bib17","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/(SICI)1097-4644(19991201)75:3<446::AID-JCB10>3.0.CO;2-I","article-title":"Secretion of glycosylation site mutants can be rescued by the signal\/pro sequence of tissue plasminogen activator","volume":"75","author":"Kohne","year":"1999","journal-title":"J Cell Biochem"},{"issue":"6","key":"10.1016\/j.vaccine.2006.05.025_bib18","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/IAI.66.6.2951-2959.1998","article-title":"Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis","volume":"66","author":"Baldwin","year":"1998","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2006.05.025_bib19","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/IAI.71.4.1672-1679.2003","article-title":"A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis","volume":"71","author":"Horwitz","year":"2003","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2006.05.025_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tube.2005.01.001","article-title":"Evaluating the role of tumor necrosis factor-alpha in experimental pulmonary tuberculosis in the guinea pig","volume":"85","author":"Lasco","year":"2005","journal-title":"Tuberculosis (Edinburgh)"},{"issue":"10","key":"10.1016\/j.vaccine.2006.05.025_bib21","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1128\/IAI.72.10.6148-6150.2004","article-title":"Protective effect of a tuberculosis subunit vaccine based on a fusion of Antigen85B and ESAT-6 in the aerosol guinea pig model","volume":"72","author":"Olsen","year":"2004","journal-title":"Infect Immun"},{"issue":"17","key":"10.1016\/j.vaccine.2006.05.025_bib22","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.vaccine.2005.01.062","article-title":"Current progress in tuberculosis vaccine development","volume":"23","author":"Orme","year":"2005","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2006.05.025_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0966-842X(00)01949-1","article-title":"Tuberculosis vaccine development: recent progress","volume":"9","author":"Orme","year":"2001","journal-title":"Trends Microbiol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2006.05.025_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tube.2004.09.009","article-title":"Evaluation of vaccines in the EU TB vaccine cluster using a guinea pig aerosol infection model of tuberculosis","volume":"85","author":"Williams","year":"2005","journal-title":"Tuberculosis (Edinburgh)"},{"key":"10.1016\/j.vaccine.2006.05.025_bib25","series-title":"Tuberculosis: pathogenesis, protection and control","first-page":"135","article-title":"Guinea pig model of tuberculosis","author":"McMurray","year":"1994"},{"issue":"5334","key":"10.1016\/j.vaccine.2006.05.025_bib26","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1126\/science.277.5334.2007","article-title":"Fluorescence-based isolation of bacterial genes expressed within host cells","volume":"277","author":"Valdivia","year":"1997","journal-title":"Science"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2006.05.025_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tube.2003.12.011","article-title":"The influence of reduced oxygen availability on pathogenicity and gene expression in Mycobacterium tuberculosis","volume":"84","author":"Bacon","year":"2004","journal-title":"Tuberculosis (Edinburgh)"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2006.05.025_bib28","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tube.2003.12.010","article-title":"Stationary phase gene expression of Mycobacterium tuberculosis following a progressive nutrient depletion: a model for persistent organisms?","volume":"84","author":"Hampshire","year":"2004","journal-title":"Tuberculosis (Edinburgh)"},{"key":"10.1016\/j.vaccine.2006.05.025_bib29","series-title":"Short protocols in molecular microbiology","author":"Ausebel","year":"1992"},{"issue":"4\u20135","key":"10.1016\/j.vaccine.2006.05.025_bib30","first-page":"209","article-title":"Identification of novel TB vaccine candidates by differential fluorescence induction","volume":"82","author":"Shuttleworth","year":"2002","journal-title":"Tuberculosis (Edinburgh)"},{"issue":"1","key":"10.1016\/j.vaccine.2006.05.025_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/protein\/10.1.1","article-title":"Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites","volume":"10","author":"Nielsen","year":"1997","journal-title":"Protein Eng"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2006.05.025_bib33","doi-asserted-by":"crossref","first-page":"S299","DOI":"10.1086\/313878","article-title":"Comparison of the protective efficacy of Bacille Calmette-Guerin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis","volume":"30","author":"Williams","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"18","key":"10.1016\/j.vaccine.2006.05.025_bib34","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1128\/JB.182.18.5238-5250.2000","article-title":"Predicted highly expressed genes of diverse prokaryotic genomes","volume":"182","author":"Karlin","year":"2000","journal-title":"J Bact"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2006.05.025_bib35","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1086\/313862","article-title":"Multiple epitopes from the Mycobacterium tuberculosis ESAT-6 antigen are recognized by antigen-specific human T cell lines","volume":"30","author":"Mustafa","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2006.05.025_bib36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2958.2003.03425.x","article-title":"Genes required for mycobacterial growth defined by high density mutagenesis","volume":"48","author":"Sassetti","year":"2003","journal-title":"Mol Micro"},{"issue":"2","key":"10.1016\/j.vaccine.2006.05.025_bib37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2958.2002.03005.x","article-title":"Role of the extracytoplasmic-function \u03c3 factor \u03c3H in Mycobacterium tuberculosis global gene expression","volume":"45","author":"Manganelli","year":"2002","journal-title":"Mol Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.05.025_bib38","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1084\/jem.20030846","article-title":"Transcriptome adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment","volume":"198","author":"Schnappinger","year":"2003","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2006.05.025_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0020-7519(87)90023-3","article-title":"Vaccination against malaria: recent advances and the problems of antigenic diversity and other parasite evasion mechanisms","volume":"17","author":"Howard","year":"1987","journal-title":"Int J Parasitol"},{"issue":"11","key":"10.1016\/j.vaccine.2006.05.025_bib40","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1128\/IAI.71.11.6116-6123.2003","article-title":"PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE family","volume":"71","author":"Okkels","year":"2003","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2006.05.025_bib41","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1128\/IAI.69.9.5606-5611.2001","article-title":"Comparative immune response to PE and PE_PGRS antigens of Mycobacterium tuberculosis","volume":"69","author":"Delogu","year":"2001","journal-title":"Infect Immun"},{"issue":"31","key":"10.1016\/j.vaccine.2006.05.025_bib42","doi-asserted-by":"crossref","first-page":"9795","DOI":"10.1021\/bi020060c","article-title":"A novel mechanism for Clostridium botulinum neurotoxin inhibition","volume":"41","author":"Eswaramoorthy","year":"2002","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.vaccine.2006.05.025_bib43","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1574-6968.1994.tb07306.x","article-title":"Zinc content of the Bacillus anthracis lethal factor","volume":"124","author":"Kochi","year":"1994","journal-title":"FEMS Microbiol Lett"},{"issue":"13","key":"10.1016\/j.vaccine.2006.05.025_bib44","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1128\/JB.187.13.4421-4429.2005","article-title":"Functional analysis of the Burkholderia cenocepacia ZmpA metalloprotease","volume":"187","author":"Kooi","year":"2005","journal-title":"J Bacteriol"},{"issue":"22","key":"10.1016\/j.vaccine.2006.05.025_bib45","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.1073\/pnas.0502159102","article-title":"Anthrax lethal factor inhibition","volume":"102","author":"Shoop","year":"2005","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2006.05.025_bib46","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1128\/IAI.72.3.1685-1692.2004","article-title":"Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis","volume":"72","author":"Derrick","year":"2004","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2006.05.025_bib47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0264-410X(03)00543-7","article-title":"Efficacy of DNA-hsp65 vaccination for tuberculosis varies with method of DNA introduction in vivo","volume":"22","author":"Lima","year":"2003","journal-title":"Vaccine"},{"issue":"5388","key":"10.1016\/j.vaccine.2006.05.025_bib48","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.282.5388.476","article-title":"Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine","volume":"282","author":"Wang","year":"1998","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.vaccine.2006.05.025_bib49","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1128\/IAI.72.11.6622-6632.2004","article-title":"The protective effect of the Mycobacterium bovis BCG vaccine is increased by co administration with the Mycobacterium tuberculosis 72-kDa fusion polypeptide Mtb72F in M. tuberculosis-infected guinea pigs","volume":"72","author":"Brandt","year":"2004","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2006.05.025_bib50","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.4049\/jimmunol.172.12.7618","article-title":"Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein","volume":"172","author":"Skeiky","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.05.025_bib51","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1472-9792(03)00054-4","article-title":"Vaccination of guinea pigs with DNA encoding Ag85A by gene gun bombardment","volume":"83","author":"Sugawara","year":"2003","journal-title":"Tuberculosis (Edinburgh)"},{"issue":"11","key":"10.1016\/j.vaccine.2006.05.025_bib52","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1128\/IAI.72.11.6471-6479.2004","article-title":"Application of Mycobacterial proteomics to vaccine design: Improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis","volume":"72","author":"Mollenkopf","year":"2004","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2006.05.025_bib53","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1128\/CMR.17.2.370-389.2004","article-title":"DNA vaccines against human immunodeficiency virus type 1 in the past decade","volume":"17","author":"Giri","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2006.05.025_bib54","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.0105-2896.2004.00138.x","article-title":"Progress in DNA-based heterologous prime-boost immunization strategies for malaria","volume":"199","author":"Moore","year":"2004","journal-title":"Immunol Rev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06005901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06005901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T16:56:24Z","timestamp":1683478584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06005901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":53,"journal-issue":{"issue":"37-39","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0264410X06005901"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.05.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}